Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial Meeting Abstract
| Authors: | Stewart, G.; Senan, S.; Spigel, D. R.; Cho, B. C.; Laktionov, K.; Zenke, Y.; Lee, K. H.; Wang, Q.; Mendivil, A. F. N.; Buchmeier, E. L.; Goksu, S. S.; Badzio, A.; Shi, A.; Daniel, D. B.; Zemanova, M.; Iyengar, P.; Paz-Ares, L. G.; Szadkowski, L.; Chugh, P.; Lai, W. C. V.; Cheng, Y. |
| Abstract Title: | Durvalumab (D) as consolidation therapy in limited-stage SCLC (LS-SCLC): Outcomes by prior concurrent chemoradiotherapy (cCRT) regimen and prophylactic cranial irradiation (PCI) use in the ADRIATIC trial |
| Meeting Title: | 23rd Annual Conference of the British Thoracic Oncology Group (BTOG) |
| Journal Title: | Lung Cancer |
| Volume: | 200 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2025 Mar 3-5 |
| Meeting Location: | Belfast, Northern Ireland |
| ISSN: | 0169-5002 |
| Publisher: | Elsevier Ireland Ltd. |
| Date Published: | 2025-02-01 |
| Start Page: | 139 |
| End Page: | 140 |
| Language: | English |
| ACCESSION: | WOS:001461207900034 |
| DOI: | 10.1016/j.lungcan.2025.108334 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 225 -- Source: Wos |
